JMIR Publications

ABSTRACT

Background:

Chronic and mental conditions are increasingly prevalent worldwide. As devices in our everyday lives offer more and more voice-based self-service, voice-based conversational agents (VCAs) have the potential to support the prevention and management of these conditions in a scalable way. VCAs allow for a more natural interaction compared to text-based conversational agents, facilitate input for users who cannot type, allow for routine monitoring and support when in-person healthcare is not possible, and open the doors to voice and speech analysis. The state of the art of VCAs for chronic and mental conditions is, however, unclear.

Objective:

This systematic literature review aims to provide a better understanding of state-of-the-art research on VCAs delivering interventions for the prevention and management of chronic and mental conditions.

Methods:

We conducted a systematic literature review using PubMed Medline, EMBASE, PsycINFO, Scopus, and Web of Science databases. We included primary research that involved the prevention or management of chronic or mental conditions, where the voice was the primary interaction modality of the conversational agent, and where an empirical evaluation of the system in terms of system accuracy and/or in terms of technology acceptance was included. Two independent reviewers conducted screening and data extraction and measured their agreement with Cohen’s kappa. A narrative approach was applied to synthesize the selected records.

Results:

Twelve out of 7’170 articles met the inclusion criteria. The majority of the studies (N=10) were non-experimental, while the remainder (N=2) were quasi-experimental. The VCAs provided behavioral support (N=5), a health monitoring service (N=3), or both (N=4). The VCA services were delivered via smartphone (N=5), tablet (N=2), or smart speakers (N=3). In two cases, no device was specified. Three VCAs targeted cancer, while two VCAs each targeted diabetes and heart failure. The other VCAs targeted hearing-impairment, asthma, Parkinson's disease, dementia and autism, “intellectual disability”, and depression. The majority of the studies (N=7) assessed technology acceptance but only a minority (N=3) used validated instruments. Half of the studies (N=6) reported either performance measures on speech recognition or on the ability of VCA’s to respond to health-related queries. Only a minority of the studies (N=2) reported behavioral measure or a measure of attitudes towards intervention-related health behavior. Moreover, only a minority of studies (N=4) reported controlling for participant’s previous experience with technology.

Conclusions:

Considering the heterogeneity of the methods and the limited number of studies identified, it seems that research on VCAs for chronic and mental conditions is still in its infancy. Although results in system accuracy and technology acceptance are encouraging, there still is a need to establish evidence on the efficacy of VCAs for the prevention and management of chronic and mental conditions, both in absolute terms and in comparison to standard healthcare.